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Abstract
 
Cabin1 binds calcineurin and myocyte enhancer factor 2 (MEF2) through its COOH-terminal
region. In cell lines, these interactions were shown to inhibit calcineurin activity after T cell re-
ceptor (TCR) signaling and transcriptional activation of Nur77 by MEF2. The role of these in-
teractions under physiological conditions was investigated using a mutant mouse strain that ex-
presses a truncated Cabin1 lacking the COOH-terminal calcineurin and MEF2 binding
domains. T and B cell development and thymocyte apoptosis were normal in mutant mice. In
response to anti-CD3 stimulation, however, mutant T cells expressed significantly higher levels
of interleukin (IL)-2, IL-4, IL-9, IL-13, and interferon 
 
 
 
 than wild-type T cells. The enhanced
cytokine gene expression was not associated with change in nuclear factor of activated T cells
(NF-AT)c or NF-ATp nuclear translocation but was preceded by the induction of a phosphor-
ylated form of MEF2D in mutant T cells. Consistent with the enhanced cytokine expression,
mutant mice had elevated levels of serum immunoglobulin (Ig)G1, IgG2b, and IgE and pro-
duced more IgG1 in response to a T cell–dependent antigen. These findings suggest that the
calcineurin and MEF2 binding domain of Cabin1 is dispensable for thymocyte development
and apoptosis, but is required for proper regulation of T cell cytokine expression probably
through modulation of MEF2 activity.
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Introduction
 
Calcineurin is a calcium and calmodulin-dependent serine/
threonine phosphatase (1–3). It is ubiquitously expressed,
but found most abundantly in the brain. Its essential role in
TCR-mediated signal transduction was first recognized
when it was identified as the target of the immunosuppres-
sive drugs cyclosporin A (CsA)
 
*
 
 and FK506 (4–11). The
primary substrates of activated calcineurin were identified
as the nuclear factor of activated T cells (NF-AT) family of
transcription factors (12, 13). Calcineurin directly dephos-
phorylates NF-AT proteins in the cytosol, resulting in their
translocation into the nucleus. Calcineurin remains associ-
 
ated with NF-AT in the nucleus, where its continued ac-
tivation by elevated calcium levels is required to sustain
NF-AT transcriptional activity (14, 15). NF-AT acts in
cooperation with other transcription factors such as acti-
vating protein 1 (AP-1) to stimulate the transcription of
many genes important for T cell activation, including sev-
eral cytokine genes such as IL-2, IL-4, and IFN-
 
 
 
.
As calcineurin is essential for transmitting cytosolic cal-
cium signals into the nucleus in T cell, its activation is
tightly controlled. Calcineurin is activated by intracellular
calcium and calmodulin (16). In resting T cells, the level of
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intracellular calcium is low and the COOH-terminal auto-
inhibitory domain binds the catalytic domain and blocks
calcineurin enzymatic activity. Upon stimulation through
TCR, the level of intracellular calcium is elevated and cal-
modulin becomes activated. Activated calmodulin then
binds to calcineurin at a site located between the catalytic
and the autoinhibitory domains, thus disrupting their inter-
action and activating calcineurin’s phosphatase activity. It is
not well understood how calcineurin activity is downmod-
ulated under physiological conditions. Although the exog-
enous small molecules CsA and FK506 have long been
known to potently inhibit calcineurin phosphatase activity,
only recently have endogenous protein inhibitors been
identified. AKAP79 (17, 18), DSCR1 (18–20), and Cab-
in1/Cain (21–26) all inhibit calcineurin activity in transfec-
tion assays in the presence of calcium signal.
Murine Cabin1 (and its rat homologue Cain) was identi-
fied in a yeast two-hybrid screen for calcineurin-interacting
proteins (23, 26). Cabin1 is a ubiquitously expressed pro-
tein of 2220 amino acids. The interacting domain in
Cabin1 was mapped to 23 amino acid residues (2117–2140)
in the COOH terminus (23). When the full-length Cabin1
or the COOH-terminal region was overexpressed in Jurkat
T cells, it inhibited the transcriptional activation of cal-
cineurin-responsive elements in the IL-2 promoter and
blocked dephosphorylation of NF-AT upon T cell activa-
tion. The interaction between Cabin1 and calcineurin is
dependent on both calcium signal and protein kinase C
(PKC) activation, which results in Cabin1 hyperphosphor-
ylation (23). As Cabin1 is found primarily in the nucleus in
T cells, it may interact only with activated calcineurin that
has translocated into the nucleus. Based on these results,
Cabin1 was hypothesized to function in down modulating
calcineurin activity during T cell activation.
In addition to binding to calcineurin, the COOH-ter-
minal region of Cabin1 was also shown to interact with
myocyte enhancer factor 2 (MEF2) and calmodulin in a
mutually exclusive manner (27, 28). MEF2 is a transcrip-
tion factor and is normally bound to its recognition se-
quence in the promoter of target genes such as the apopto-
sis-inducing gene Nur77 in thymocytes (27, 29). Binding
of Cabin1 to MEF2 suppresses MEF2 transcriptional activ-
ity through recruitment of the mSin3 corepressor complex
via the NH
 
2
 
-terminal region of Cabin1 (27). However, in
the presence of a calcium signal, calmodulin binds to
Cabin1, freeing MEF2 to recruit the coactivator p300 for
transcriptional activation of MEF2 target genes. Consistent
with this model, overexpression of Cabin1 in a DO11.10
T cell hybridoma prevents induction of Nur77 by MEF2
and protects the cells from TCR-mediated apoptosis (28).
As MEF2 is critical for the transcription of Nur77 in thy-
mocytes, Cabin1 may also regulate thymocyte apoptosis
during early T cell development.
To examine the role of the calcineurin- and MEF2-
binding domains of Cabin1 in T cell development and
function under physiological conditions, we generated
Cabin1
 
 
 
C mice, which produce a truncated Cabin1 lack-
ing the last 123 amino acid residues from the C-terminus.
 
Contrary to expectation, we found that TCR-mediated
thymocyte apoptosis was unaffected by the Cabin1
 
 
 
C mu-
tation, indicating that the interaction between Cabin1 and
MEF2 is not essential for regulating thymocyte apoptosis in
vivo. However, in response to anti-CD3 stimulation, mu-
tant T cells expressed elevated levels of cytokines and a dif-
ferent form of MEF2D. In addition, Cabin1
 
 
 
C mice pro-
duced an enhanced T cell–dependent IgG1 antibody
response. These results demonstrate that Cabin1 normally
downmodulates T cell effector functions.
 
Materials and Methods
 
Targeting Construct and Generation of Cabin1
 
 
 
C Mice.
 
A
cDNA fragment encoding the COOH-terminal calcineurin
binding domain of Cabin1 was used to isolate Cabin1 genomic
clones from a 129/SvJ library. Sequencing of genomic clones
identified the last three exons of Cabin1, 3
 
 
 
 untranslated se-
quences and polyadenylation site (Fig. 1 A). The targeting vector
contained 2.5 kb of 5
 
 
 
 homologous sequence, a loxP-flanked,
pgk promoter-driven neomycin
 
r
 
 (
 
neo
 
r
 
) cassette, 4.5 kb of 3
 
 
 
 ho-
mologous sequence, and the thymidine kinase gene. Homolo-
gous recombination in embryonic stem cells should result in the
replacement of a 0.7 kb EcoRI-BamHI fragment with the 
 
neo
 
r
 
cassette. The linearized vector was transfected into J1 ES cells by
electroporation and transfectants were selected with G418 and
gancyclovir. Resistant clones were screened for homologous re-
combinants by Southern blot with various probes (data not
shown). 15 homologous recombinant ES clones were obtained
and two were injected into blastocysts from C57Bl/6 mice. Chi-
meras produced from both clones transmitted the mutant allele to
their offspring. Chimeras were bred with Cre deleter mice (30) to
remove the 
 
neo
 
r
 
 cassette by Cre/loxP recombination, and het-
erozygous offspring were interbred to produce homozygous mu-
tant mice (Cabin1
 
 
 
C). Offspring were genotyped by either
Southern blot analysis of tail DNA or PCR assays using primers
5
 
 
 
-caatgtgtggacagcctggacccaggc and 5
 
 
 
-gcagctcccaggcggctgccag-
gttcc. Mice were housed in specific pathogen-free facilities.
 
Flow Cytometric Analysis.
 
Single-cell suspensions of spleen,
thymus, or lymph node were prepared. Erythrocytes were re-
moved from splenocyte suspensions by lysis with 0.14 M NH
 
4
 
Cl
and 17 mM Tris-HCl, pH 7.4. Cells were incubated on ice with
FITC-, APC-, or PE-conjugated antibodies (BD PharMingen)
and analyzed on a FACScalibur™ (Becton Dickinson) with
CELLQuest™ software. Dead cells were gated out with propid-
ium iodide (PI).
 
Thymocyte Apoptosis.
 
Thymocytes were plated at 1.5 
 
 
 
 10
 
6
 
cells/ml on plates precoated with 50 
 
 
 
g/ml anti-CD3 (2C11) in
RPMI supplemented with 10% FBS, 10 mM HEPES, 50 
 
 
 
M
2-mercaptoethanol, 2 mM L-glutamine, 100 U/ml penicillin,
and 100 
 
 
 
g/ml streptomycin. Annexin V-FITC (BD PharMin-
gen) binding assay was performed according to manufacturer’s
instructions.
 
T Cell Purification.
 
Total T cells were purified from spleen
and lymph nodes using anti-CD4 and anti-CD8 magnetic beads
on SuperMACS cell sorter or AutoMACS machine (Miltenyi
Biotec). For purifying CD4 T cells, anti-CD4 magnetic beads
were used. Cell purity was usually 
 
 
 
95%.
 
Analysis of T Cell Activation.
 
For T cell proliferation and cy-
tokine secretion assays, 2.5 
 
 
 
 10
 
5
 
 purified CD4 T cells or total
lymph node cells were incubated in 0.2 ml RPMI plus supple-
ments in a 96-well plate. The cells were stimulated with plate- 
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bound anti-CD3 antibody (2C11), or PMA plus ionomycin. CsA
was added at 2 
 
 
 
M. Supernatants were collected for cytokine as-
says 48 h after stimulation. Some cultures were pulsed with
[
 
3
 
H]thymidine at 48 h and harvested 18 h later.
 
ELISA Assays for Cytokines and Antibodies.
 
IL-2 and IFN-
 
 
 
in activated CD4 T cell culture supernatants were assayed using
commercial kits from Biosource International and R&D Sys-
tems, respectively. Serum Ig levels of unimmunized mice were
measured by coating plates with anti-IgH plus IgL antibodies
(Southern Biotechnology Associates, Inc.), and developing with
horseradish peroxidase (HRP)-coupled goat antibodies specific
for each mouse Ig isotype. ELISA for IgE was performed by
coating the plates with anti-IgE antibody (BD PharMingen) and
developing with HRP-conjugated anti-IgE antibody (BD
PharMingen). NP-specific antibody in serum from immunized
mice was measured by coating plates with NP-BSA and devel-
oping with HRP-coupled goat antibodies specific for each
mouse Ig isotype.
 
RNase Protection Assay.
 
Total RNA was isolated from lymph
node cells or anti-CD3 stimulated lymph node cells (Ultraspec).
The levels of cytokine transcripts were measured by RNase pro-
tection assay using the Riboquant multiprobe kit (BD PharMin-
gen) following the manufacturer’s instructions. After overnight
hybridization of target RNA with 
 
32
 
P-labeled RNA probe, the
protected mRNAs were purified and resolved on a 6% denatur-
ing polyacrylamide gel. Cytokine transcript levels were quantified
on a PhosphorImager (Molecular Dynamics) using ImageQuant
software.
 
Western Blot Analysis.
 
The thymus and brain from wild-type
and Cabin1
 
 
 
C mice were lysed in lysis buffer (50 mM Tris-HCl,
pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% NP-40, and protease
inhibitor cocktail; Roche Molecular Biochemical) by Dounce ho-
mogenizer. Lysate containing 750 
 
 
 
g of proteins was immunopre-
cipitated with anti-Cabin1 polyclonal antibodies that specifically
recognize the COOH-terminal 77 amino acid residues of Cabin1.
Lysate and antibodies were incubated for 2 h at 4
 
 
 
C in the pres-
ence of protein A/G Sepharose beads and precipitates were
washed three times with lysis buffer. Proteins in precipitates were
separated on SDS-PAGE, transferred to nitrocellulose membrane,
and probed with the anti-Cabin1 polyclonal antibodies.
For detection of Nur77, protein concentration of thymocyte
lysates was measured by BCA protein assay (Pierce Chemical
Co.), and equal amounts of wild-type and Cabin1
 
 
 
C lysate were
immunoprecipitated with anti-Nur77 antibody (Santa Cruz Bio-
technology, Inc.). Western blotting was performed as above ex-
cept anti-Nur77 antibody was used.
For detection of NF-AT translocation and MEF2D induction,
nuclear extracts were isolated from purified T cells as described
(31). Protein concentration of the extracts was measured by BCA
protein assay, and 50 
 
 
 
g of each nuclear extract was resolved by
SDS-PAGE, transferred to PVDF membrane, and probed se-
quentially with antibodies specific for NF-ATc, NF-ATp, and
MEF2D (BD PharMingen).
 
Ig Class Switching Assay.
 
For B cell class switching assays, 5 
 
 
 
10
 
5
 
 splenocytes were cultured in 2 ml RPMI plus supplements in
24-well plate. B cells were stimulated with 10 
 
 
 
g/ml LPS or with
10 
 
 
 
g/ml plate-bound anti-CD40 (BD PharMingen) in the pres-
ence or absence of 50 ng/ml IL-4 (R&D Systems). After 5 d, the
cells were stained with antibodies to B220 (BD PharMingen) and
IgG1 (Southern Biotechnology Associates, Inc.) and analyzed by
flow cytometry.
 
Immunization.
 
8- to 12-wk-old mice were immunized with
the T cell–dependent antigen (4-hydroxyl-3-nitrophenyl) acetyl-
 
conjugated KLH (NP-KLH). 20 
 
 
 
g of NP-KLH in 0.2 ml PBS
were injected intravenously through the tail vein on day 0 and
the mice were bled on day 14. On day 21, mice were boosted
with the same amount of antigen intravenously and bled on day
28. NP-specific antibodies in the serum were measured by
ELISA.
 
Results
 
Cabin1
 
 
 
C Mice.
 
Cabin1 is a large and widely expressed
protein that probably has multiple functions in different cell
types. We reasoned that deleting the entire protein in mice
would be likely to result in severe and pleiotropic effects,
making it difficult to assess the importance of Cabin1’s in-
teractions with calcineurin and MEF2 in T cell develop-
ment and function. Therefore, we targeted only the last
two exons of Cabin1, which encode the COOH-terminal
calcineurin, calmodulin, and MEF2 binding domains. As
shown in Fig. 1 A, a 0.7-kb EcoRI-BamHI fragment con-
taining the last two coding exons and part of the 3
 
 
 
 un-
translated region was replaced by a 
 
neo
 
r
 
 cassette by homolo-
gous recombination in ES cells. Chimeras derived from the
targeted ES cell clones were bred with Cre deleter mice
(30) to remove the loxP-flanked 
 
neo
 
r
 
 cassette, and het-
erozygous mice were interbred to produce Cabin1
 
 
 
C
mice homozygous for the Cabin1 truncation (Fig. 1, A and
B). In the absence of the 
 
neo
 
r
 
 cassette, transcription of the
truncated allele is expected to go through the downstream
intron, into the remaining 3
 
 
 
 untranslated region, and ter-
minate at the normal polyadenylation site. Translation of
the mutant transcript would continue into the intron until
it reaches an in-frame stop codon after 11 nucleotides, pro-
ducing a truncated Cabin1 protein with 4 new amino acid
residues at the COOH terminus (Fig. 1 A).
Homozygous Cabin1
 
 
 
C mice were born at the ex-
pected Mendelian ratio, were healthy, and reproduced nor-
mally. Northern blotting using a cDNA probe that hybrid-
ized to a region of Cabin1 upstream of the deleted region
revealed a Cabin1 transcript at the expected size in brain
and thymus of Cabin1
 
 
 
C mice, although at a twofold re-
duced level (Fig. 1 D). Amplification of the mutant tran-
scripts by reverse transcription (RT)-PCR and cloning and
sequencing of the products confirmed that the transcripts
have the expected 3
 
 
 
 sequence (data not shown). A West-
ern blot analysis using antibodies specific for the COOH-
terminal domain of Cabin1 readily detected Cabin1 in
brain and thymus extracts of wild-type but not Cabin1
 
 
 
C
mice, demonstrating the expected deletion in the mutant
mice (Fig. 1 C). However, identification of the truncated
Cabin1 protein by Western blotting in Cabin1
 
 
 
C mice
was hampered by the lack of a good antibody specific for
the NH
 
2
 
 terminus of Cabin1 despite our repeated attempts
to generate such an antibody.
In targeting the Cabin1 locus, we inserted the 
 
neo
 
r
 
 cas-
sette in the opposite transcriptional orientation of the
Cabin1 gene. As the 
 
neo
 
r
 
 cassette is known to have a dis-
ruptive effect on gene expression (32), we hypothesized
that the insertion could cause a more severe disruption of 
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Cabin1 transcription, resulting in a null allele. Indeed,
when heterozygous Cabin1-neo mice were interbred, no
homozygous pups were obtained in over 200 offspring
genotyped. Examination of embryos after timed matings
 
revealed that homozygous Cabin1-neo mice died in utero
around embryonic day 12.5. Although we cannot rule out
the possibility that the embryonic lethality is caused by in-
terference of the 
 
neo
 
r
 
 cassette with the expression of a
neighboring gene, Cabin1 is ubiquitously expressed and has
no known homologs, and a Cabin1 null allele is likely to
cause embryonic lethality. The dramatic difference be-
tween the phenotype of Cabin1
 
 
 
C and Cabin1-neo mice
supports our assertion that Cabin1
 
 
 
C mice produce a trun-
cated protein, while Cabin1-neo mice have a null allele.
 
Normal T and B Cell Development in Cabin1
 
 
 
C Mice.
 
To determine the effect of the Cabin1
 
 
 
C mutation on
lymphocyte development, the cellularity and surface phe-
notype of cells from various lymphoid organs were exam-
ined. The numbers of thymocytes in Cabin1
 
 
 
C mice were
similar to those in wild-type littermates at various ages ex-
amined (Fig. 2). Distribution of CD4
 
 
 
CD8
 
 
 
 (double
negative [DN]), CD4
 
 
 
CD8
 
 
 
 (double positive [DP]), and
CD4
 
 
 
, or CD8
 
 
 
 (single positive [SP]) thymocytes was also
similar between the wild-type and Cabin1
 
 
 
C mice.
Within the DN thymocyte population, similar proportions
of cells were found to express CD25 and/or CD44 in the
wild-type and Cabin1
 
 
 
C mice (data not shown). In DP
thymocytes, surface expression of CD69 is transiently up-
regulated when the cells undergo positive selection (33)
and the differentiation from DP to SP is associated with
upregulation of TCR
 
 
 
 and downregulation of heat stable
antigen (HSA). No difference was detected in TCR
 
 
 
 and
HSA expression and in percentages of CD69
 
 
 
 cells in DP
Figure 1. Generation of Cabin1 C mice. (A) Schematic diagrams of
the 3  region of the murine Cabin1 genomic locus and the Cabin1-neo
and Cabin1 C alleles. Filled box, coding sequence; open box, 3  un-
translated region; triangle, loxP site; and filled circle, poly A site. DNA
sequences at the exon-intron boundary on the Cabin1 C allele are
shown. Capital letters refer to nucleotides from the exon and lowercase
refers to nucleotides from the intron. Reading frames and the in frame
stop codon (bold) 11 nucleotides into the intronic sequence are indicated.
(B) Southern blot analysis for Cabin1 C deletion. Tail DNA was di-
gested with BamHI and the filter was hybridized with a 0.8 kb BamHI-
EcoRI probe as diagrammed in A. DNA fragments generated from the
wild-type (wt) and Cabin1 C ( C) allele are indicated. (C) Western blot
analysis for Cabin1 protein. Equal amount of lysates from brain and thy-
mus of Cabin1 C and wild-type mice were immunoprecipitated with
polyclonal antibodies specific for the COOH-terminal 77 amino acid res-
idues of Cabin1. Precipitates were separated on SDS-PAGE, transferred
to nitrocellulose membrane, and probed with the anti-Cabin1 polyclonal
antibodies. Anti-actin monoclonal antibody was used for the detection of
actin as a control. (D) Northern blot analysis for Cabin1 transcripts. 5  g
of poly(A)  RNA from various tissues of wild-type and Cabin1 C mice
were fractionated by formaldehyde-agarose gel and the filters was hybrid-
ized with a 1.2 kb Cabin1 cDNA fragment located 5  to the deleted
Cabin1 sequence. The same filter was stripped and rehybridized with a
GAPDH probe.
Figure 2. T and B cell development proceeds normally in Cabin1 C
mice. Flow cytometric analysis of lymphoid tissues from Cabin1 C mice
( C) and wild-type controls ( / ). The numbers above the plots are the
average number of thymocytes in Cabin1 C mice (n   5) and wild-type
littermates (n   4). Thymocytes, lymph node cells, or splenocytes were
stained with the indicated antibodies, and the numbers indicate the per-
centages of cells within the quadrants or gated area.1453 Esau et al.
thymocytes between the wild-type and Cabin1 C mice
(data not shown).
The total numbers of T cells and the ratio of CD4  and
CD8  T cells in lymph nodes and spleen did not differ sig-
nificantly between wild-type and Cabin1 C mice (Fig. 2).
There was no increase in the proportion of T cells that
expressed the activation markers CD69 and CD25 in
Cabin1 C mice compared with wild-type mice (data not
shown), indicating that the Cabin1 C mutation does not
cause spontaneous activation of T cells. We observed no
gross defects in B cell development in the bone marrow
(data not shown), and there was a normal proportion of
B220  and IgM  B cells in the spleen of Cabin1 C mice
(Fig. 2). Together, these results demonstrate that deletion
of the COOH-terminal domain of Cabin1 does not appar-
ently affect T and B cell development.
Normal Thymocyte Apoptosis in Cabin1 C Mice. To test
whether the Cabin1 C mutation has an effect on TCR-
mediated apoptosis of thymocytes, we treated thymocytes
with plate-bound anti-CD3 antibody in vitro. As measured
by propidium iodide (PI) uptake and Annexin V binding,
the number of dead and apoptotic cells in the Cabin1 C
thymocyte cultures was similar to that of wild-type at 24 or
48 h after stimulation (Fig. 3 A). Similarly, no significant
difference in thymocyte apoptosis was observed between
the two types of mice that were injected with anti-CD3
antibodies (data not shown). Analysis of Nur77 induction
by immunoprecipitation and Western blotting showed that
a similar level of Nur77 protein was induced in wild-type
and Cabin1 C thymocytes after anti-CD3 treatment while
no Nur77 protein was detected in untreated thymocytes
(Fig. 3 B). Thus, the COOH-terminal MEF2- and cal-
cineurin-binding domain of Cabin1 is not essential for
proper regulation of thymocyte apoptosis.
Enhanced Cytokine Production by Cabin1 C T Cells.
Next we examined the effect of the Cabin1 C mutation
on T cell activation in vitro. Lymph node cells from
Cabin1 C mice and wild-type controls were stimulated
with an optimal amount of plate-bound anti-CD3 (10  g/
ml) or PMA (5 ng/ml) plus ionomycin (250 ng/ml). Up-
regulation of the activation markers CD69 and CD25 on T
cells was monitored every day for 3 d, and no difference in
the kinetics or the levels of induction was observed be-
tween the wild-type and Cabin1 C T cells (data not
shown). To better detect difference in response between
the mutant and wild-type T cells, purified CD4 T cells
were stimulated with different concentrations of anti-CD3
antibody or an optimal concentration of PMA plus differ-
ent concentrations of ionomycin. Proliferation of the stim-
ulated T cells was measured by [3H]thymidine incor-
poration. Both the wild-type and Cabin1 C T cells
proliferated vigorously to optimal concentrations of PMA
and ionomycin but not much to suboptimal concentrations
of ionomycin (Fig. 4 A, top panel). At different concentra-
tions of anti-CD3, mutant CD4 T cells proliferated more
extensively than wild-type cells, although in some experi-
ments no difference was detected (data not shown).
Culture supernatants of activated CD4 T cells were ana-
lyzed for the levels of IL-2 and IFN-  by ELISA. At differ-
ent anti-CD3 concentrations, significantly higher levels of
IL-2 ( 5-fold) and IFN-  ( 2-fold) were detected in cul-
tures of Cabin1 C T cells than that of wild-type T cells
(Fig. 4 A, middle and bottom panels). However, after stim-
ulation with more potent stimuli, such as anti-CD3 plus
anti-CD28 or PMA plus ionomycin, the levels of IL-2 and
IFN-  produced by Cabin1 C T cells were similar to
those of wild-type T cells (Fig. 4 A, and data not shown).
In the presence of CsA, no IL-2 or IFN-  were detected in
the supernatants of either Cabin1 C or wild-type cultures
(data not shown), indicating that the enhanced cytokine
production depends on phosphatase activity of calcineurin.
To determine whether the increased levels of IL-2 and
IFN-  in the supernatants were a result of increased tran-
scription of these genes in Cabin1 C T cells, we quanti-
fied cytokine transcripts in anti-CD3 stimulated lymph
node T cells by RNase protection assay (Fig. 4 B). The
levels of cytokine transcripts in each sample were normal-
ized to the level of transcript of ribosomal protein L32.
Transcripts for IFN- , IL-2, IL-9, IL-13, and IL-4 were
consistently found to be two- to threefold more abundant
in Cabin1 C T cells than in wild-type T cells at 48 h. The
increase for some cytokine transcripts was already detect-
able at 24 h. These results clearly demonstrate that deletion
Figure 3. TCR-mediated apoptosis and induction of Nur77 in thy-
mocytes of Cabin1 C and wild-type mice. (A) Thymocytes from 6-wk-
old Cabin1 C mice (n   5) and wild-type littermates (n   4) were stim-
ulated individually in vitro with 50  g/ml plate-bound anti-CD3 for the
indicated times. Annexin V binding of thymocytes was measured by flow
cytometry. The percentages shown are after subtraction of background
(Annexin V  thymocytes in unstimulated cultures). (B) Pooled thy-
mocytes from 6-wk-old Cabin1 C mice and wild-type littermates were
stimulated as above for 3 h. Cell lysates containing equal amounts of pro-
tein were immunoprecipitated with anti-Nur77. Precipitates were sepa-
rated by SDS-PAGE, transferred to nitrocellulose membrane, and probed
with the same anti-Nur77 antibody.1454 Cabin1 in T Cell Development
of the COOH-terminal region of Cabin1 results in an en-
hanced cytokine gene expression in T cells after TCR-
mediated activation.
Impaired MEF2D Induction in Cabin1 C T Cells. Of
the three NF-AT family members selectively expressed in
T cells, NF-ATc (NF-ATc1, NF-AT2) and NF-ATp (NF-
ATc2, NF-AT1) are thought to be responsible for regulat-
ing calcineurin-dependent cytokine transcription in mature
T cells (34, 35). To investigate whether the increased cyto-
kine expression in Cabin1 C T cells is mediated through
increased activation of NF-AT by calcineurin, we exam-
ined NF-ATc and NF-ATp translocation to the nucleus af-
ter stimulation of T cells with anti-CD3. No NF-ATc or
NT-ATp was detected by Western blotting in the nucleus
of unstimulated T cells (Fig. 5). After stimulation, how-
ever, several isoforms of NF-ATc and NF-ATp were de-
tected but no significant difference in the level was de-
tected between wild-type and Cabin1 C T cells. By gel
mobility shift assay for total nuclear NF-AT activity, no
significant difference was detected between mutant and
wild-type T cells at 4, 24, or 48 h (data not shown). How-
ever, significant difference in MEF2D induction in the two
types of T cells was detected (Fig. 5). Without stimulation,
MEF2D was not detected in the nucleus of wild-type T
cells but was readily detected 4 h after anti-CD3 stimula-
tion. In contrast, in mutant T cells, significantly lower lev-
els of MEF2D were detected at all three time points and
the residual MEF2D migrated more slowly on the SDS-
PAGE, indicating a difference in posttranslational modifi-
cation. These results show that the enhanced cytokine gene
expression in Cabin1 C T cells is correlated with alter-
ations in MEF2D induction but not NF-AT activation.
Enhanced Ig Production in Cabin1 C Mice. The en-
hanced cytokine gene expression by activated T cells could
result in an enhanced T cell–dependent antibody response
in Cabin1 C mice. We assayed the levels of the various
immunoglobulin isotypes in the serum of 3-mo-old
Cabin1 C and wild-type mice. As shown in Fig. 6, the
Figure 4. Enhanced cytokine production by
Cabin1 C T cells. (A) Purified CD4 T cells from
Cabin1 C ( C) and wild-type ( / ) mice were ei-
ther not treated, or treated with indicated concentra-
tions of anti-CD3, or 5 ng/ml of PMA plus the indi-
cated concentrations of ionomycin for 48 h. T cell
proliferation (top panel) was measured by pulsing the
cultures with [3H]thymidine for 18 h after initial stimu-
lation. The levels of IL-2 (middle panel) and IFN- 
(bottom panel) were measured in the culture superna-
tants after 48 h of stimulation. The assays were per-
formed in triplicate. The proliferation and cytokine as-
says were also performed with total lymph node cells
five and three times, respectively. Similar results were
obtained except that in some experiments no difference
in proliferation was observed between mutant and
wild-type T cells (not shown). (B) RNase protection
assay for cytokine transcripts. Lymph node cells from
Cabin1 C and wild-type controls were stimulated for
24 and 48 h with 10  g/ml anti-CD3, and total RNA
was isolated. The levels of cytokine transcripts were as-
sayed by RNase protection. Transcript levels were
quantified by phosphorimager and normalized to the
levels of transcript for the ribosomal protein L32 in
each lane. The numbers indicate the fold-increase of
specific cytokine transcript in Cabin1 C T cells over
that in the wild-type T cells at 48 h. The entire assay
was repeated three times with similar results.
Figure 5. Nuclear translocation of NF-ATc and NF-ATp and induc-
tion of MEF2D. Purified T cells from Cabin1 C mice ( C) and wild-
type controls ( / ) were either not stimulated or stimulated with plate-
bound anti-CD3 for 4, 24, and 48 h. Nuclear extracts containing equal
amounts of protein (50  g) were separated by SDS-PAGE, transferred to
membrane, and probed sequentially with antibodies specific for NF-ATc,
NF-ATp, and MEF2D.1455 Esau et al.
level of IgG1, IgG2b, and IgE was three, two, and sixfold
higher, respectively, in Cabin1 C mice than in wild-type
mice. No significant difference was observed in the levels
of IgM, IgG3, or IgG2a. To compare antibody response to
T cell–dependent antigen between Cabin1 C and wild-
type mice, mice were immunized with NP-KLH on day 0
and day 21 and bled on day 14 and 28. The levels of NP-
specific IgG1 and IgG2b, but not IgM, IgG2a, or IgG3,
were modestly, though significantly, higher in Cabin1 C
than wild-type mice at day 14 (primary response, Fig. 7). In
the secondary response (day 28), NP-specific IgG1 was still
significantly higher in the mutant mice than in the wild-
type mice. No difference was detected in antibody re-
sponse to a T cell–independent antigen NP-Ficoll between
mutant and wild-type mice (data not shown). Together,
these results show that T cell–dependent IgG1 antibody re-
sponse is selectively enhanced in Cabin1 C mice.
Normal IgG1 Class Switching in Cabin1 C B Cells. The
enhanced IgG1 response in Cabin1 C mice could result
from the increased cytokine production by T cells, or an
alteration in B cells that favors class switching to IgG1. It is
known that CD40 signaling in B cells is CsA-sensitive (36,
37) and that stimulation through CD40 strongly enhances
IL-4–dependent class switching to IgG1 (38). Stimulation
of B cells with LPS plus IL-4 also induces IgG1 class
switching, but LPS signaling is not sensitive to CsA (37).
To examine whether B cells from Cabin1 C mice are in-
trinsically more efficient in class switching, we compared
IgG1 class switching between wild-type and mutant B cells
in vitro under the same stimulation conditions. In the ab-
sence of IL-4,  1% of B cells from either wild-type or
Cabin1 C mice expressed cell surface IgG1 after 5 d of
stimulation with LPS or anti-CD40 (Fig. 8). In the pres-
ence of IL-4,  15 and 35% of B cells expressed IgG1 after
LPS and anti-CD40 stimulation, respectively. However, no
difference was detected in the frequency of class switching
between wild-type and mutant B cells, indicating that the
elevated levels of IgG1 in the serum of Cabin1 C mice is
not due to an alteration of B cell signaling that results in
more efficient class switching.
Discussion
Calcineurin is critical for integrating calcium signal with
the downstream effector functions in T cells, partly by reg-
ulating the activity of NF-AT family of transcription factors
and therefore T cell activation and cytokine expression (3).
Recently, calcineurin was also shown to modulate MEF2
activity either directly (39) or indirectly through NF-ATp,
which can form a ternary complex with MEF2 (40).
Cabin1 was initially identified as a calcineurin and MEF2
binding protein and was shown to suppress their activities
in transfection assays in T cell lines (23, 28). To investigate
the physiological role of Cabin1 interaction with cal-
cineurin and MEF2 in developing T cells, we determined
the effect of deleting the calcineurin and MEF2 binding
domain of Cabin1 on T cell development and function in
mice.
T and B cell development in Cabin1 C mice was nor-
mal (Fig. 2), indicating that the interaction between
Cabin1 and calcineurin and MEF2 is not required for lym-
phocyte development. Based on previous studies in T cell
lines (28), DP thymocytes from Cabin1 C mice were ex-
pected to be more susceptible to TCR-mediated apoptosis.
Presumably, the truncated Cabin1 cannot bind MEF2 and
recruit the mSin3 corepressor complex to inhibit MEF2
from activating the transcription of the pro-apoptotic gene
Nur77. However, compared with wild-type thymocytes,
Figure 6. Serum Ig levels are elevated in Cabin1 C mice. The levels
of Ig isotypes in the serum of 3-mo-old Cabin1 C and wild-type mice
were measured by ELISA. Each symbol represents one mouse. An un-
paired Student’s t test was used to determine the P values.
Figure 7. Enhanced IgG1 antibody response to
NP-KLH in Cabin1 C mice. Mice at 8–12 wk of
age were immunized intravenously with NP-KLH
in PBS on day 0 and 21 and bled on day 14 and 28.
The levels of NP-specific Ig isotypes were mea-
sured by ELISA with NP-BSA coated plates.
OD450nm at the linear range of serum dilutions is
shown and each symbol represents one mouse. For
the primary response, serum dilution of 1/750 was
used for all isotypes and for secondary response, se-
rum dilutions for IgG1, 2a, 2b, and 3 were 1/125,000,
1/25,000, 1/5,000, and 1/25,000, respectively. An
unpaired Student’s t test was used to determine the
P values.1456 Cabin1 in T Cell Development
Cabin1 C thymocytes were not more susceptible to apop-
tosis and were not induced to express a higher level of
Nur77 after TCR stimulation (Fig. 3). Thus, while overex-
pression of Cabin1 or its COOH terminus in a T cell hy-
bridoma can suppress TCR-mediated apoptosis, Cabin1’s
interaction with MEF2 is not uniquely required for the
negative regulation of MEF2 in developing thymocytes.
The lack of effect of Cabin1 C on thymocyte apoptosis is
not surprising, however, in light of the recent reports of
redundant MEF2 transcriptional corepressors including
MEF2 interacting transcription repressor (MITR), histone
deacetylases 4 and 5 (41–45). The inhibition of MEF2 by
these corepressors is also calcium-dependent but does not
require Cabin1 as an intermediary (42, 45). It is likely that
the redundant MEF2 transcriptional corepressors can com-
pensate for the Cabin1 COOH-terminal deletion.
Different from thymocytes, anti-CD3 stimulation of
CD4 T cells from Cabin1 C mice resulted in an enhanced
transcription of IL-2, IL-4, IL-9, IL-13, and IFN-  (Fig.
4), which are all target genes of NF-AT transcription fac-
tors. These results are complementary to those observed in
T cells deficient in both NF-ATc (NF-ATc1, NF-AT2)
and NF-ATp (NF-ATc2, NF-AT1), in which production
of many cytokines is reduced after stimulation through
TCR (46). The increased cytokine gene expression was in-
hibited by the presence of CsA, indicating the requirement
for calcineurin activity. Considering that overexpression of
the COOH-terminal region of Cabin1 inhibits calcineurin
activity in T cell lines, the enhanced cytokine gene tran-
scription in Cabin1 C T cells seems likely to be mediated
by increased calcineurin activity. However, we did not de-
tect any increase in nuclear translocation of NF-ATc and
NF-ATp in mutant T cells compared with wild-type T
cells (Fig. 5). It is possible that the NF-AT assays used were
not sensitive enough to detect a relatively small difference,
which may be sufficient to account for the observed two-
to threefold increase in cytokine gene expression. How-
ever, as NF-AT are the major downstream targets of cal-
cineurin, the lack of detectable difference in NF-ATc and
NF-ATp between wild-type and Cabin1 C T cells sug-
gests that the deletion in Cabin1 may not affect calcineurin
activity. Although we did not measure calcineurin activity
directly, the normal T cell development in mutant mice,
and the normal activation of CD69 and CD25 expression
and largely normal proliferation of mutant T cells are con-
sistent with this interpretation.
In contrast to lack of change in NF-AT nuclear translo-
cation, the level of MEF2D induction was significantly
lower in Cabin1 C T cells than in wild-type T cells and
the residual MEF2D displayed a slower mobility on SDS-
PAGE (Fig. 5). Based on the electrophoretic mobility of
MEF2D and phosphorylated MEF2D (47–49), the differ-
ence in the observed MEF2D mobility between mutant
and wild-type T cells is likely due to phosphorylation of
MEF2D in Cabin1 C T cells. Thus, Cabin1-MEF2 inter-
action is required for proper MEF2D induction and phos-
phorylation after TCR signaling. Various studies have
shown that different members of mitogen-activated pro-
tein (MAP) kinase phosphorylate different members of
MEF2. For example, p38 preferentially phosphorylates
MEF2A and 2C (47, 50) whereas big mitogen-activated
protein kinase (BMK1) preferentially phosphorylates MEF2A,
2C, and 2D (49). Because calcineurin may directly dephos-
phorylate MEF2 (39), it appears that the interaction be-
tween Cabin1 and calcineurin and MEF2 may be required
for MEF2D dephosphorylation by calcineurin in activated
T cells.
The altered MEF2D induction probably contributes to
the enhanced cytokine gene expression in Cabin1 C T
cells because MEF2D is induced by TCR signaling and its
induction precedes cytokine gene expression (4 h versus
24 h, Figs. 4 and 5). Most studies suggest that phosphorylation
of specific sites in MEF2A and MEF2D activates their
transactivating activity (47, 49, 50). Members of the MEF2
family transcription factors promote transcription of target
genes by binding to the MEF2 binding site in the promoter
region as homo- and heterodimers. MEF2D is also capable
of enhancing NF-AT activity by forming a ternary com-
plex with NF-ATp (40, 51). In addition, consensus MEF2
binding sites (g/t c/t t a a/t a/t a/t a t a a/g a/c/t [52]) can
be identified in the promoter regions of cytokine genes
such as IL-2, IL-4, IL-9, IL-13, and IFN-  (data not
shown) although none of these sites has been shown to be
functional. Thus, among many possibilities, a simple mech-
anism can be envisioned whereby phosphorylated MEF2D
can directly promote cytokine gene expression in Cabin1 C
T cells either as homodimer or heterodimer with other
Figure 8. Class switching to IgG1 is unaffected in Cabin1 C B cells.
Splenocytes from wild-type and Cabin1 C mice were stimulated in vitro
for 5 d with LPS or anti-CD40 in the presence or absence of IL-4. Cells
were stained with antibodies specific for IgG1 and B220, and analyzed by
flow cytometry. Splenocytes from three wild-type and three Cabin1 C
mice were assayed, and one representative plot for each stimulation is
shown. The numbers indicate percentages of B220  cells that are IgG1 .1457 Esau et al.
MEF2 family members or NF-AT. Although the precise
mechanisms have yet to be elucidated, our findings strongly
suggest that Cabin1 is a negative regulator of cytokine gene
expression in T cells. It appears that upon TCR ligation,
activation of MAP kinases may result in the phosphoryla-
tion of MEF2D, which promotes cytokine gene expres-
sion. Interaction of Cabin1 and MEF2D may result in the
dephosphorylation of MEF2D and thus the downmodula-
tion of T cell effector function.
The Cabin1 C mutant mice have elevated levels of se-
rum IgG1, IgG2b, and IgE and produce higher levels of
IgG1 in response to a T cell–dependent antigen NP-KLH
(Figs. 6 and 7). The enhanced antibody response is appar-
ently not due to an intrinsic alteration of B cells in the mu-
tant mice. After anti-IgM or LPS stimulation in vitro, B
cells from Cabin1 C and wild-type mice expressed similar
levels of activation markers CD25 and proliferated to the
same extent (data not shown). Furthermore, the proportion
of mutant and wild-type B cells that switched to IgG1 in
response to anti-CD40 and IL-4 stimulation was the same
(Fig. 8) although stimulation of IgG1 class switch through
CD40 in B cells is known to involve calcineurin (36, 37).
The observed elevation in serum Ig levels in Cabin1 C
mice is likely to be promoted by the increased levels of cy-
tokines secreted by Cabin1 C T cells. Class switching to
IgG1 and IgE isotypes is normally induced by IL-4 secreted
by Th2 cells, and class switching to IgG2a isotype is pro-
moted by IFN-  produced by Th1 cells. Although produc-
tion of both Th2- and Th1-type cytokines were increased
in Cabin1 C T cells after anti-CD3 stimulation in vitro,
no significant increase in IgG2a was observed in the serum
of nonimmunized mice or in response to NP-KLH immu-
nization. The difference in cytokine expression in vitro and
T helper cell development in vivo probably reflects differ-
ences in activation conditions during an immune response
in mice and T cell activation in culture. It is also possible
that cytokine production by non-T cells could be affected
by the Cabin1 C mutation and contributed to the elevated
serum Ig isotypes. However, because the increased IgG1
production was observed even when Cabin1 C mice were
immunized with NP-KLH in the absence of adjuvant (Fig.
7), cytokines produced by non-T cells were probably not a
major contributor.
The biological function of calcineurin and NF-AT was
initially elucidated in lymphocytes whereas the function of
MEF2 was initially identified in muscle cells. Various stud-
ies have now shown that calcineurin and NF-AT also play
critical roles in muscle and neuronal cell development and
function whereas MEF2 may play a role in T cell develop-
ment and neuronal cell function. In this report, we exam-
ined the role of the COOH terminus of Cabin1, encom-
passing the calcineurin- and MEF2-binding domain, in
lymphocyte development and function and our findings
provide the strongest evidence to date for a role of Cabin1
and MEF2D in T cell cytokine gene expression. Cabin1
has also been implicated in regulation of neurotransmitter
endocytosis in neuronal cells (25), and muscle cell develop-
ment (21, 22, 24). Although the gross phenotype of the
Cabin1 C mice gave no indication of a major defect in the
development and function of muscle cells or the nervous
system, we have yet to examine the effect of the mutation
on these processes. Together, calcineurin, NF-AT, Cabin1,
and MEF2 are a group of interacting proteins that convert
calcium signal into different effector functions in diverse
biological systems.
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